70 related articles for article (PubMed ID: 37210575)
1. CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer.
Zhang X; Zheng X; Ying X; Xie W; Yin Y; Wang X
J Transl Med; 2023 May; 21(1):334. PubMed ID: 37210575
[TBL] [Abstract][Full Text] [Related]
2. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
[TBL] [Abstract][Full Text] [Related]
3. Cell-cycle related centromere protein F deficiency suppresses ovarian cancer cells growth by inducing ferroptosis.
Liu X; Guo L; Suo Y; Tang X; Zhu T; Zhao T; Zhang W; Zhang P
Gynecol Obstet Invest; 2024 May; ():. PubMed ID: 38723616
[TBL] [Abstract][Full Text] [Related]
4. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m
Chen SJ; Zhang J; Zhou T; Rao SS; Li Q; Xiao LY; Wei ST; Zhang HF
Redox Biol; 2024 Feb; 69():102975. PubMed ID: 38042059
[TBL] [Abstract][Full Text] [Related]
6. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract][Full Text] [Related]
7. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression.
Mo X; Liu Q; Liang K; Song Y
J Bioenerg Biomembr; 2024 Jun; 56(3):333-345. PubMed ID: 38488992
[TBL] [Abstract][Full Text] [Related]
8. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer.
Li M; Ni QY; Yu SY
Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
[TBL] [Abstract][Full Text] [Related]
9. KCNA1 promotes the growth and invasion of glioblastoma cells through ferroptosis inhibition via upregulating SLC7A11.
Wang W; Zhang Y; Li X; E Q; Jiang Z; Shi Q; Huang Y; Wang J; Huang Y
Cancer Cell Int; 2024 Jan; 24(1):7. PubMed ID: 38172959
[TBL] [Abstract][Full Text] [Related]
10. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment.
Zhao Y; Chen Y; Wan Q; Xiao C; Guo Z; Du X; Hu Y; Zheng A; Cao Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16391-16406. PubMed ID: 37707574
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the Clinical Relevance of Ferroptosis-Related Genes in Human Ovarian Aging.
Lin PH; Li CJ; Lin LT; Su WP; Sheu JJ; Wen ZH; Cheng JT; Tsui KH
Reprod Sci; 2023 Dec; 30(12):3529-3536. PubMed ID: 37500975
[TBL] [Abstract][Full Text] [Related]
12. Ischemia/reperfusion-activated ferroptosis in the early stage triggers excessive inflammation to aggregate lung injury in rats.
Liu X; Pan B; Wang X; Xu J; Wang X; Song Z; Zhang E; Wang F; Wang W
Front Med (Lausanne); 2023; 10():1181286. PubMed ID: 37425328
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-related signature and immune infiltration characterization in acute lung injury/acute respiratory distress syndrome.
Ma A; Feng Z; Li Y; Wu Q; Xiong H; Dong M; Cheng J; Wang Z; Yang J; Kang Y
Respir Res; 2023 Jun; 24(1):154. PubMed ID: 37301835
[TBL] [Abstract][Full Text] [Related]
14. Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma.
Li XM; Liu SP; Li Y; Cai XM; Zhang SB; Xie ZF
Heliyon; 2023 Aug; 9(8):e18436. PubMed ID: 37520990
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic and Proteomic Analysis Reveals the Potential Role of RBMS1 in Adipogenesis and Adipocyte Metabolism.
Dairi G; Al Mahri S; Benabdelkamel H; Alfadda AA; Alswaji AA; Rashid M; Malik SS; Iqbal J; Ali R; Al Ibrahim M; Al-Regaiey K; Mohammad S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511060
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.
Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
[TBL] [Abstract][Full Text] [Related]
17. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
18. STEAP3 Affects Ovarian Cancer Progression by Regulating Ferroptosis through the p53/SLC7A11 Pathway.
Han Y; Fu L; Kong Y; Jiang C; Huang L; Zhang H
Mediators Inflamm; 2024; 2024():4048527. PubMed ID: 38440354
[TBL] [Abstract][Full Text] [Related]
19. Role of SLC7A11/xCT in Ovarian Cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract][Full Text] [Related]
20. The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer.
Chen B; Zhao L; Yang R; Xu T
Front Genet; 2023; 14():1275154. PubMed ID: 38028615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
